Salmon SE - Search Results

1

In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs.

Alberts DS, Dorr RT, Wunz TP, Remers WA, Einspahr J, Liu R, Salmon SE. Alberts DS, et al. Among authors: salmon se. Anticancer Drugs. 1991 Feb;2(1):69-77. doi: 10.1097/00001813-199102000-00010. Anticancer Drugs. 1991. PMID: 1958855

2

Effects of granulocyte-macrophage colony-stimulating factor on in vitro growth of human solid tumors.

Salmon SE, Liu R. Salmon SE, et al. J Clin Oncol. 1989 Sep;7(9):1346-50. doi: 10.1200/JCO.1989.7.9.1346. J Clin Oncol. 1989. PMID: 2671290

3

In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.

Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R, Salmon SE. Federico M, et al. Among authors: salmon se. Gynecol Oncol. 1994 Dec;55(3 Pt 2):S156-63. doi: 10.1006/gyno.1994.1356. Gynecol Oncol. 1994. PMID: 7835801

4

Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor.

Dorr RT, Dvorakova K, Snead K, Alberts DS, Salmon SE, Pettit GR. Dorr RT, et al. Among authors: salmon se. Invest New Drugs. 1996;14(2):131-7. doi: 10.1007/BF00210783. Invest New Drugs. 1996. PMID: 8913833

5

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.

Alberts DS, Fanta PT, Running KL, Adair LP Jr, Garcia DJ, Liu-Stevens R, Salmon SE. Alberts DS, et al. Among authors: salmon se. Cancer Chemother Pharmacol. 1997;39(6):493-7. doi: 10.1007/s002800050604. Cancer Chemother Pharmacol. 1997. PMID: 9118460

6

Novel antitumor 2-cyanoaziridine-1-carboxamides.

Iyengar BS, Dorr RT, Alberts DS, Hersh EM, Salmon SE, Remers WA. Iyengar BS, et al. Among authors: salmon se. J Med Chem. 1999 Feb 11;42(3):510-4. doi: 10.1021/jm980600x. J Med Chem. 1999. PMID: 9986721

7

Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro.

Hersh EM, Gschwind CR, Taylor CW, Dorr RT, Taetle R, Salmon SE. Hersh EM, et al. Among authors: salmon se. J Natl Cancer Inst. 1992 Aug 19;84(16):1238-44. doi: 10.1093/jnci/84.16.1238. J Natl Cancer Inst. 1992. PMID: 1640482

8

A phase I and pharmacokinetic study of intravenous vinzolidine.

Taylor CW, Salmon SE, Satterlee WG, Robertone AB, McCloskey TM, Holdsworth MT, Plezia PM, Alberts DS. Taylor CW, et al. Among authors: salmon se. Invest New Drugs. 1990;8 Suppl 1:S51-7. doi: 10.1007/BF00171984. Invest New Drugs. 1990. PMID: 2380017

9

Phase I-II trial of interferon-alpha 2b by continuous subcutaneous infusion over 28 days.

Dorr RT, Salmon SE, Robertone A, Bonnem E. Dorr RT, et al. Among authors: salmon se. J Interferon Res. 1988 Dec;8(6):717-25. doi: 10.1089/jir.1988.8.717. J Interferon Res. 1988. PMID: 3230330

10

Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).

Alberts DS, Einspahr JG, Struck R, Bignami G, Young L, Surwit EA, Salmon SE. Alberts DS, et al. Among authors: salmon se. Invest New Drugs. 1984;2(2):141-8. doi: 10.1007/BF00232343. Invest New Drugs. 1984. PMID: 6469507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters